The previous page is sending you to https://pipelinereview.com/index.php/2020080275462/Antibodies/FDA-Approves-MonjuviR-tafasitamab-cxix-in-Combination-with-Lenalidomide-for-the-Treatment-of-Adult-Patients-with-Relapsed-or-Refractory-Diffuse.

 If you do not want to visit that page, you can return to the previous page.